1-Naphthylmethcathinone

Pharmaceutical compound From Wikipedia, the free encyclopedia

1-Naphthylmethcathinone (AMAPN) is a monoamine releasing agent of the cathinone and naphthylaminopropane families.[1][2] It is an analogue of methcathinone in which the phenyl ring has been replaced with a 1-naphthalene ring.[1][2]

Other namesAMAPN
CAS Number
Quick facts Clinical data, Other names ...
1-Naphthylmethcathinone
Clinical data
Other namesAMAPN
Drug classSerotonin–norepinephrine–dopamine releasing agent
Identifiers
  • 2-(methylamino)-1-naphthalen-1-ylpropan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC14H15NO
Molar mass213.280 g·mol−1
3D model (JSmol)
  • CC(C(=O)C1=CC=CC2=CC=CC=C21)NC
  • InChI=1S/C14H15NO/c1-10(15-2)14(16)13-9-5-7-11-6-3-4-8-12(11)13/h3-10,15H,1-2H3
  • Key:QIACKSHQBOUATI-UHFFFAOYSA-N
Close

The drug acts as a potent serotonin–norepinephrine–dopamine releasing agent (SNDRA).[1][2] Its EC50Tooltip half-maximal effective concentration values for induction of monoamine release are 21.6 nM for serotonin and 55.2 nM for dopamine, whereas the EC50 for norepinephrine was not reported.[1] However, AMAPN induced 92% release of norepinephrine at a concentration of 10,000 nM, indicating that it is an effective norepinephrine releaser as well.[1]

See also

References

Related Articles

Wikiwand AI